drugset / Trial / NCT00931541

AZD6088 Single Ascending Dose Study

NCT00931541 ↗

Phase 1 Completed 35 enrolled AstraZeneca
RandomizedParallel-groupTriple-blindBasic science

Summary

The aims of the study are to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD6088 following single ascending dose administration in healthy male and non-fertile females.

Timeline

Start
2009-06
Primary completion
—
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD6088 Small molecule — Oral

Indications

No indication recorded.